Next |
home / stock / krbp / krbp message board
Subject | By | Source | When |
---|---|---|---|
in the red now fun while it lasted | koolmc | investorshub | 04/17/2023 6:33:53 PM |
znewcar1: $KRBP hod6.96 PMH7.75 flushed | znewcar1 | investorshangout | 04/17/2023 3:36:14 PM |
Wild | Awl416 | investorshub | 04/17/2023 10:37:23 AM |
$KRBP...................................https://stockcharts.com/h-sc/ui?s=$KRBP&p= | glenn1919 | investorshub | 04/15/2023 7:15:44 PM |
There she goes | Awl416 | investorshub | 04/14/2023 8:34:21 PM |
5.20's nice pull that crazy move next week biatch | koolmc | investorshub | 04/14/2023 8:23:53 PM |
going again | koolmc | investorshub | 04/14/2023 7:55:22 PM |
hit 4.80 :) took some of table, i | koolmc | investorshub | 04/14/2023 3:00:14 PM |
nice chomp chomp | koolmc | investorshub | 04/13/2023 3:06:23 PM |
Big block | Awl416 | investorshub | 04/13/2023 2:53:19 PM |
$KRBP $5+ explosion yesterday but I guess the | wickerman | investorshub | 04/04/2023 7:43:50 PM |
If this can break 5.11 vatch out then. | BEIJING BILL | investorshub | 04/04/2023 1:23:29 PM |
znewcar1: $KRBP 32% v828K c5.265 f683,490 H6.54 RL3.71 | znewcar1 | investorshangout | 03/14/2023 8:57:18 PM |
Fun day | Awl416 | investorshub | 03/14/2023 7:22:31 PM |
Wow, someone's stop loss got taken out. | Alias12345 | investorshub | 03/10/2023 7:51:42 PM |
$KRBP inturusting here. | BEIJING BILL | investorshub | 03/09/2023 4:14:36 PM |
znewcar1: $KRBP 21% v5,0M c.1845 f20,5M H.194 ML.138 | znewcar1 | investorshangout | 03/09/2023 3:53:00 AM |
My key words are these --> | wickerman | investorshub | 03/01/2023 6:45:55 PM |
KEY WORD: PRE-CLINICAL | TheFinalCD | investorshub | 02/28/2023 2:22:43 PM |
$KRBP nice news out this could squeeze over .50 | wickerman | investorshub | 02/28/2023 1:34:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Kiromic BioPharma Inc. Company Name:
KRBP Stock Symbol:
NASDAQ Market:
Kiromic BioPharma Inc. Website:
Follow-up Findings Show Stable Disease FDA and IRB Approve IND for a Single-Use, Single-Patient Treatment with Deltacel Fast Track Designation Request Submitted to FDA Complete Enrollment in Trial’s Second Cohort Expected in July Kiromic BioPharma, Inc. ...
Favorable Follow-up Findings Include Stable Disease and a 13% Decrease in Tumor Size Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) reports favorable six-month follow-up results from the first patient enrolled in the Deltacel-01 Phase ...
Scans of this first patient in the second cohort show 8.5% reduction in tumor size Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) reports favorable safety and tolerability, and early efficacy in the fourth patient enrolled in the Compa...